Cohort study of malignant tumor patients

Cohort study of malignant tumor patients - Cohort study of malignant tumor patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069408

Enrollment

Unknown

Registered

2023-03-15

Start date

2022-06-13

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

Group of malignancy:Comprehensive tumor therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Patients with pathological or clinical diagnosis of advanced malignant tumors; 3. Fully understand the content of this study, and have the ability to follow the follow-up of the research plan, sign the informed consent form, and voluntarily participate in this researcher. Patients who meet the above 3 items at the same time can be included in this study

Exclusion criteria

Exclusion criteria: Cognitive impairment.

Design outcomes

Primary

Measure	Time frame
Tumor Markers;Imaging indicators;EuroQol Five Dimensions Questionnaire (EQ-5D);FACT-G_ENG_Final_Ver4_16Nov07;MDASI-Core_Chinese-Simplified_CURRENT_SAMPLE;	—

Secondary

Measure	Time frame
blood routine;Liver function;Renal function;Biochemical Indicators;Coagulation;	—

Countries

China

Contacts

Public ContactZhou Kun

The Second Affiliated Hospital of Chongqing Medical University

zhoukun@hospital.cqmu.edu.cn+86 15923098669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026